The Indian Council of Medical Research (ICMR) is focusing on providing an oral formulation of Hydroxyurea to address sickle cell disease (SCD) among children.
About the Hydroxyurea:
- Hydroxyurea, also known as Hydroxycarbamide, is part of the antimetabolites class of medications.
- It treats SCD by inhibiting the formation of sickle-shaped red blood cells.
- Besides SCD, Hydroxyurea is used to treat thrombocythemia, leukemia, and cervical cancer.
Quick fact:
- SCD is a prevalent monogenic disorder in India.
Ref: Source
| UPSC IAS Preparation Resources | |
| Current Affairs Analysis | Topperspedia |
| GS Shots | Simply Explained |
| Daily Flash Cards | Daily Quiz |